(6AS,7R,13S,14R,16R)-16-((((1,1-DIMETHYLETHYL)DIMETHYLSILYL)OXY)METHYL)-6,6A,7,13,14,16-HEXAHYDRO-5-HYDROXY-9-METHOXY-8-(METHOXYMETHOXY)-4,10,17-TRIMETHYL-7,13-IMINO-12H-1,3-DIOXOLO(7,8)ISOQUINO(3,2-B)(3)BENZAZOCINE-14-CARBONITRILE
UNII QV2WU4T6JZ
Substance Identification & Data
This profile provides standardized clinical and technical data for (6as,7r,13s,14r,16r)-16-((((1,1-dimethylethyl)dimethylsilyl)oxy)methyl)-6,6a,7,13,14,16-hexahydro-5-hydroxy-9-methoxy-8-(methoxymethoxy)-4,10,17-trimethyl-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocine-14-carbonitrile, uniquely identified by the FDA Unique Ingredient Identifier (UNII) QV2WU4T6JZ.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 265134-87-0 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C34H47N3O7Si YGNVHJMSBZNMAV-VEBUABNOSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for (6as,7r,13s,14r,16r)-16-((((1,1-dimethylethyl)dimethylsilyl)oxy)methyl)-6,6a,7,13,14,16-hexahydro-5-hydroxy-9-methoxy-8-(methoxymethoxy)-4,10,17-trimethyl-7,13-imino-12h-1,3-dioxolo(7,8)isoquino(3,2-b)(3)benzazocine-14-carbonitrile. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.